Benzodizepine action is associated with this neurotransmitter system:
cholinergic
adrenergic
glycine
glutamate
GABA
Benzodiazepine especially effective in managing panic disorder:
triazolam (Halcion)
flurazepam (Dalmane)
flumazenil (Romazicon)
alprazolam (Xanax)
thiopental (Pentothal)
Probably acts by binding to a component of the GABA receptor-coupled chloride channel, prolonging the duration of channel open state when the receptor is exposed to GABA:
chlordiazepoxide (Librium)
pentobarbital (Nembutal)
fentanyl (Sublimaze)
imipramine (Tofranil)
doxepin (Sinequan)
Petit mal and myoclonic seizures:
phenytoin (Dilantin)
clonazepam (Klonopin)
primidone (Mysoline)
triazolam (Halcion)
phenobarbital (Luminal)
Effective in managing acute ethanol withdrawal:
buspirone (BuSpar)
chlorpromazine (Thorazine)
amantidine (Symmetrel)
diazepam (Valium)
tranylcypromine (Parnate)
Barbiturates: lipid solubility and ionization:
lipid insoluble; weak base
lipid insoluble; weak acid
lipid soluble; weak acid
lipid soluble; weak base
Rapid anesthetic-induction agent;i.v. route of administration:
pentobarbital (Nembutal)
thiopental (Pentothal)
ethosuximide (Zarontin)
lorazepam (Ativan)
chloral hydrate (Noctec)
CNS depressant(s):
paraldehyde
pentobarbital (Nembutal)
lorazepam (Ativan)
B & C
A, B & C
Not classified as a CNS depressant, but causes significant sedation:
triazolam (Halcion)
imipramine (Tofranil)
phenobarbital (Luminal)
ethanol
flumazenil (Romazicon)
Anxiolytic: Serotonin-1A receptor sites--
flurazepam (Dalmane)
chloral hydrate (Noctec)
buspirone (BuSpar)
paraldehyde
meprobamate
Chronic use increases liver microsomal enzyme activity and increases urine production by inhibiting ADH.
phenobarbital (Luminal)
ethanol
triazolam (Halcion)
B & C
A, B & C
Tolerance and physical dependence not observed with this anxiolytic:
lorazepam (Ativan)
chloral hydrate (Noctec)
buspirone (BuSpar)
paraldehyde
meprobamate
Duration of barbiturate action mainly depends on:
rate of hepatic metabolism
excretion rate from renal and/or pulmonary systems
lipid solubility and time to distribute throughout the body
pharmacogenetic differents between patients
If you wish to return to the Table of Contents in ENGLISH, press
the RETURN button above.
Otherwise, if the text is NOT displayed in English and
you are ready to leave this page,
Press here
to return to the Table of Contents